Larimar Therapeutics, Inc. (LS:A2P5PP) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Flynn Other companies: Lite Strategy, Inc. (Director · Since at least Oct 31, 2023); Nuvalent, Inc. (Director · Since at least Jul 28, 2021); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); Oruka Therapeutics, Inc. (Director · Jan 30, 2024 – Jan 30, 2024 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Sep 12, 2016 · Past); AveXis Inc (Director · Sep 3, 2015 – Feb 10, 2016 · Past) | Director · Since at least May 28, 2020 |
| Robert J Perez Other companies: Rapport Therapeutics, Inc. (Director · Since at least Nov 7, 2024); Immunocore Holdings plc (Director · Jan 2, 2024 – Jan 2, 2024 · Past); Third Harmonic Bio Inc. (Director · Sep 14, 2022 – Mar 6, 2023 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 22, 2023 · Past); Cogent Biosciences, Inc. (Director · Mar 28, 2018 – Jun 14, 2019 · Past); Spark Therapeutics Inc (Director · Jan 3, 2018 – Dec 17, 2019 · Past); Decoy Therapeutics Inc. (Director · Sep 2, 2015 – Jul 26, 2017 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 22, 2017 · Past); AMAG Pharmaceuticals Inc (Director · Jan 26, 2009 – May 16, 2019 · Past); Cubist Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 3, 2006 – Jan 21, 2015 · Past) | Director · Sep 24, 2015 – Jun 26, 2019 · Past |
| Jeffrey S. Hatfield Other companies: Vir Biotechnology, Inc. (Chair of the Board · Since at least Dec 9, 2020); Viridian Therapeutics, Inc. (Director · Aug 10, 2017 – Feb 4, 2021 · Past); aTyr Pharma, Inc. (Director · Apr 3, 2017 – May 6, 2020 · Past); InVivo Therapeutics Holdings Corp (Director · Nov 1, 2016 – Jan 19, 2018 · Past); Vitae Pharmaceuticals Inc (Chief Executive Officer, Director · Sep 24, 2014 – Oct 24, 2016 · Past); Ambit Biosciences Corp (Director · Jun 2, 2014 – Nov 10, 2014 · Past) | Chief Executive Officer, Director · Oct 9, 2017 – Jan 22, 2019 · Past |
| Jonathan Leff Other companies: BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); Alpine Immune Sciences Inc (Director · Jun 16, 2015 – Sep 11, 2015 · Past); InterMune Inc (EVP, Research & Development · Feb 27, 2012 – Sep 29, 2014 · Past) | Director · Since at least May 28, 2020 |
| Kevin P Starr Other companies: MyoKardia Inc (Director · Oct 28, 2015 – Mar 7, 2018 · Past); Global Blood Therapeutics Inc (Director · Aug 11, 2015 – Aug 17, 2015 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Jun 15, 2023 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Feb 19, 2015 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2017 · Past); Human Genome Sciences Inc (Director · May 3, 2007 – Jul 10, 2007 · Past) | Director · Jun 18, 2014 – Sep 24, 2015 · Past |
| Alicia Secor Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Juniper Pharmaceuticals Inc (President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past) | Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past |
| Thomas Daniel Other companies: Gossamer Bio, Inc. (Director · Since at least Feb 7, 2019); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past); Juno Therapeutics Inc (Director · Aug 11, 2015 – Mar 5, 2018 · Past); Epizyme Inc (Director · May 30, 2013 – May 30, 2013 · Past); Celgene Corporation (see remarks · Feb 15, 2012 – Dec 31, 2015 · Past) | Director · Mar 3, 2016 – May 12, 2021 · Past |
| Jeffrey Sherman Other companies: Xeris Biopharma Holdings, Inc. (Director · Since at least Oct 5, 2021); Strongbridge Biopharma plc (Director · Jan 1, 2018 – Oct 5, 2021 · Past); Horizon Pharma PLC (EVP and Chief Medical Officer · Jul 28, 2011 – Mar 23, 2018 · Past); Idm Pharma Inc (Sr. VP, R & D and CMO · Aug 29, 2007 – Apr 3, 2008 · Past) | Director · Since at least Oct 3, 2023 |
| Dennis Kim Other companies: Skye Bioscience, Inc. (Chief Medical Officer · Aug 21, 2019 – Aug 7, 2020 · Past); Sesen Bio Inc (Chief Medical Officer · Dec 3, 2018 – Dec 3, 2018 · Past); Orexigen Therapeutics Inc (Sr. VP, Corporate Development · Feb 27, 2009 – Apr 23, 2009 · Past) | Chief Medical Officer · Jun 18, 2014 – Jan 22, 2019 · Past |
| Frank E Thomas Other companies: Spero Therapeutics, Inc. (Director · Since at least Nov 1, 2017); Orchard Therapeutics PLC (See Remarks · Jan 1, 2020 – Jan 24, 2024 · Past); AMAG Pharmaceuticals Inc (President & COO · Feb 23, 2017 – Feb 23, 2017 · Past) | Director · Since at least Jun 30, 2016 |
| John L. LaMattina Other companies: Ligand Pharmaceuticals Incorporated (Director · Since at least May 31, 2012); Immunome, Inc. (Director · Oct 1, 2020 – Jun 8, 2023 · Past); Human Genome Sciences Inc (Director · May 17, 2012 – Jul 30, 2012 · Past) | Director · Jun 18, 2014 – Jun 26, 2019 · Past |
| Michael Celano Other companies: Recro Pharma Inc (Chief Operating Officer · Jul 5, 2016 – Jan 18, 2019 · Past); Kensey Nash Corp (Chief Financial Officer · Mar 10, 2009 – Jun 22, 2012 · Past); OraSure Technologies, Inc. (Director · Oct 4, 2006 – Aug 12, 2022 · Past) | Chief Financial Officer · Since at least May 28, 2020 |
| Peter Barrett Other companies: Obsidian Therapeutics, Inc. (Director · Since at least Aug 3, 2026); Synlogic Inc (Chairman, Partner, Atlas Venture · Since at least Jun 9, 2022); Revvity, Inc. (Partner, Atlas Venture · Since at least May 6, 2022) | Director · May 10, 2022 – May 10, 2022 · Past |
| Carole Ben-Maimon Other companies: Teligent Inc (Director · Mar 29, 2016 – Jul 21, 2021 · Past); Impax Laboratories Inc (President, Global Pharm. · Sep 6, 2011 – May 14, 2014 · Past) | President and CEO, Director · Since at least May 28, 2020 |
| Frank E. Thomas Other companies: Spero Therapeutics, Inc. (Chairman of the Board; Audit Committee Chair · Since at least Apr 28, 2025) | Director · Since at least Nov 4, 2026 |
| John B Harlow Jr Other companies: Esperion Therapeutics, Inc. (Chief Commercial Officer · Since at least Nov 17, 2025) | President and COO · Since at least Sep 29, 2026 |
| Joseph Truitt Other companies: Century Therapeutics, Inc. (Director · Since at least Sep 9, 2026) | BOARD CHAIR · Since at least May 10, 2022 |
| Thomas E Hughes Other companies: Viridian Therapeutics, Inc. (Director · Feb 13, 2017 – May 21, 2020 · Past) | See Remarks, Director · Jun 18, 2014 – Jun 28, 2018 · Past |
| Thomas Hamilton Other companies: Annaly Capital Management Inc. (Director · Since at least Mar 6, 2019) | Director · Since at least May 28, 2020 |
| Adrienne Clements-Egan | Vice President, Bioanalytics and Developability · Since at least Nov 5, 2026 |
| Brian McVeigh | Chief Business Officer · May 29, 2018 – Jan 22, 2019 · Past |
| Francis Michael Conway | VICE PRESIDENT AND CONTROLLER · Since at least Nov 5, 2026 |
| Frank Nazzario | Vice President, Commercial · Since at least Nov 4, 2026 |
| Gopi Shankar | Chief Development Officer · Since at least Feb 7, 2023 |
| Jennifer Johansson | Vice President, Legal and Compliance · Since at least Nov 5, 2026 |
| John Berman | Vice President of Finance and Administration · Since at least Nov 5, 2026 |
| John Harlow | President and Chief Operating Officer · Since Sep 29, 2026 |
| Keith E. Lynch | Vice President, CMC Technical Operations · Since at least Nov 5, 2026 |
| Mohamed Hamdani | Vice President, Statistics and Quantitative Sciences · Since at least Nov 5, 2026 |
| Noreen Scherer | Vice President of Clinical Operations · Since at least Nov 5, 2026 |
| Patrick Loustau | President · Jun 18, 2014 – Mar 31, 2016 · Past |
| Russell Clayton | Chief Medical Officer · Since at least Jul 17, 2023 |
| Rusty Clayton | Chief Medical Officer · Since at least Feb 24, 2026 |
| Tom Hamilton | Director · Since at least Jul 8, 2026 |
| Wendy Everett | Director · Jun 26, 2019 – Jun 26, 2019 · Past |